
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Koselugois a precision small molecule MEK inhibitor designed for specific tumor types, especially in the treatment of neurofibromatosis (NF1).Is Koselugoeffective?The therapeutic e···【more】
Article source:Captain MedicineRelease date:2024-08-22Recommended:577
Koselugo is a carefully developed small molecule MEK blocker (also known as a mitogen activation inhibitor) whose core medical strategy focuses on precisely targeting targeted inte···【more】
Article source:Captain MedicineRelease date:2024-08-22Recommended:564
As the world's first drug specifically for the treatment of cachexia, Anamorelin helps patients restore their appetite and increase weight and muscle mass by stimulating ghreli···【more】
Article source:Captain MedicineRelease date:2024-08-22Recommended:533
Anamorelin is a drug that mimics the function of ghrelin in the human body, which can increase appetite and increase muscle mass, and is used to improve weight and appetite problem···【more】
Article source:Captain MedicineRelease date:2024-08-22Recommended:540
Koselugo is a carefully developed small molecule MEK inhibitor (also known as a Schengen-activated antagonist) with a focus on precisely targeted therapies for specific tumor types···【more】
Article source:Captain MedicineRelease date:2024-08-22Recommended:469
Koselugo is a class of finely designed small molecule MEK blockers (also known as mitogen activation inhibitors), and its core therapeutic strategy is targeted therapy for specific···【more】
Article source:Captain MedicineRelease date:2024-08-22Recommended:478
Koselugo is a precisely targeted small molecule MEK inhibitor with a therapeutic focus on targeted therapies targeting specific tumor types, especially in the treatment of neurofib···【more】
Article source:Captain MedicineRelease date:2024-08-22Recommended:477
Koselugo is a class of precision small molecule MEK inhibitors (also regarded as schizogenic activation antagonists), and its core efficacy focuses on targeted therapy for specific···【more】
Article source:Captain MedicineRelease date:2024-08-22Recommended:527
Koselugo is a small molecule MEK inhibitor (figogen activation inhibitor) that is mainly used for the treatment of certain types of tumors, especially in the treatment of neurofibr···【more】
Article source:Captain MedicineRelease date:2024-08-22Recommended:504
Anamorelin is a drug for cancer cachexia that increases a patient's appetite and weight by mimicking the effects of ghrelin. This drug can significantly improve the nutritional···【more】
Article source:Captain MedicineRelease date:2024-08-21Recommended:626
As a selective ghrelin receptor agonist, anamolin is approved in Japan for improving the health of cancer cachexia patients. By promoting appetite and gaining weight, it has a posi···【more】
Article source:Captain MedicineRelease date:2024-08-21Recommended:420
Through its unique pharmacological effects, Anamoreline is effective in helping cancer patients overcome weight loss and loss of appetite. Drugs have shown therapeutic potential in···【more】
Article source:Captain MedicineRelease date:2024-08-21Recommended:383
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:8532025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:10502024-09-07
Recently, Lao Lucius Pharmaceutical (Lucius Pharmaceuticals) issued a solemn statement regarding cou···【more】
Recommended:3102026-10-10
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended:4052026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended:5982026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended:5702026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended:4562026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended:6072026-31-07

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643